Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab.

[1]  H. Gaissert,et al.  Overview of malignant tracheal tumors. , 2018, Annals of cardiothoracic surgery.

[2]  N. Hellenthal,et al.  Survival trends in patients with tracheal carcinoma from 1973 to 2011. , 2017, American journal of otolaryngology.

[3]  D. D. de Alwis,et al.  Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Mino‐Kenudson,et al.  Successful Treatment of an Aggressive Tracheal Malignancy With Immunotherapy. , 2017, The Annals of thoracic surgery.

[5]  Y. Shentu,et al.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. , 2016, The New England journal of medicine.

[6]  M. Hayward,et al.  Management and prognosis of primary tracheal cancer: A national analysis , 2014, The Laryngoscope.

[7]  M. Simoff.  Endobronchial management of advanced lung cancer. , 2001, Cancer control : journal of the Moffitt Cancer Center.